Results 31 to 40 of about 141,527 (280)

Antioxidant capacity of Chuquiraga spinosa Less and Senecio rhizomatus Rusby and their effects on the progression of testosterone enanthate-induced prostatic hyperplasia in rats [PDF]

Journal of Pharmacy & Pharmacognosy Research
Context: Benign prostatic hyperplasia affects men older than 50 years and can progress to atypical prostatic hyperplasia. Conventional pharmacotherapy causes adverse effects, affecting adherence and leading to the use of phytotherapy as a complementary ...
Hugo Jesús Justil-Guerrero, Jorge Luis Arroyo-Acevedo, Juan Pedro Rojas-Armas, Carlos Javier Justil-Guerrero, María Cecilia Rondón-Ramos, Jessica Yolanda Huarcaya-Rojas   +5 more
doaj   +1 more source

The Influencing Role of Diabetes Mellitus and Hypertension in the Establishment of Benign Prostatic Hyperplasia

Journal of Nobel Medical College, 2020
Background: Benign prostatic hyperplasia is regarded as non-malignant growth of prostatic tissueIt is the most common benign tumor in men, and the incidence is age related. In men aged more than 50 years, it is the fourth most prevalent disease.
Ram Sagar Shah, Rabindra Tamang
doaj   +1 more source

Studies on Chromatographic Fingerprint and Fingerprinting Profile-Efficacy Relationship of Saxifraga stolonifera Meerb.

Molecules, 2015
This work investigated the spectrum-effect relationships between high performance liquid chromatography (HPLC) fingerprints and the anti-benign prostatic hyperplasia activities of aqueous extracts from Saxifraga stolonifera.
Xing-Dong Wu, Hua-Guo Chen, Xin Zhou, Ya Huang, En-Ming Hu, Zheng-Meng Jiang, Chao Zhao, Xiao-Jian Gong, Qing-Fang Deng   +8 more
doaj   +1 more source

Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. [PDF]

, 1993
associated with aging. Thus, the question arises whether or not a correlation exists between the well known prostatic androgen and estrogen accumulation and aging.
Nass, Ralf, Tunn, Sabine, Krieg, Michael, M. Krieg   +3 more
core   +2 more sources

Immunohistochemical Expression of Nkx3.1 in Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia at a Tertiary Care Hospital in Karachi

Journal of Gandhara Medical and Dental Sciences, 2023
OBJECTIVES To determine NKX3.1 expression in prostatic adenocarcinoma and benign prostate hyperplasia on Immunohistochemistry at a tertiary care hospital in Karachi.
Beenish Hussain, Syeda Naveera Raza, Amna Hussain, Ramsha Faridi, Saman Nadeem, Yusra Saleem   +5 more
doaj   +1 more source

The band electrode: Ongoing experience with a novel turp loop to improve hemostasis in 265 patients [PDF]

, 2004
Introduction: Intraoperative bleeding, one of the major complications of conventional transurethral resection of the prostate ( TURP), has led to a search for various alternative methods of tissue ablation in patients with benign prostatic hyperplasia ...
Reich, O., Faul, P.
core   +1 more source

Quantitation of α_1A and α_1D-adrenoceptor mRNA in prostate tissues from patients with symptomatic benign prostatic hyperplasia

Journal of Pathology of Nepal, 2011
Background: To treat symptomatic benign prostatic hyperplasia α1-adrenoceptor antagonists with little antagonism at α1b-adrenoceptor were used to avoid orthostatic hypotension.
B Acharya, H Okada, G Aryal, T Shirakawa, N Hinata, A Gotoh   +5 more
doaj   +1 more source

Silodosin in the treatment of benign prostatic hyperplasia. [PDF]

, 2010
Benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) are highly prevalent in older men. Medical therapy is the first-line treatment for LUTS due to BPH.
Rossi, Maxime, Maxime Rossi, null Maxime Rossi, Roumeguere, Thierry, Thierry Roumeguère, Thierry Roumeguere   +5 more
core   +1 more source

Benign Prostatic Hyperplasia in a 13-Year-Old Boy

, 2023
Benign prostatic hyperplasia (BPH) is most common in men 40 years and above. It rarely occurs in childhood. As a result of the scarcity of cases, the pathogenesis is not clear, and treatment of BPH in this age group is challenging. This report focuses on
Dennis Inyangala, Gitobu Mburugu, Maxwell Gachie, James Ikol, Chrispine Onyango Oluoch   +4 more
core   +1 more source

MEDICAL TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AFTER CYSTOLITHOTRIPSY [PDF]

Zagazig University Medical Journal, 2018
Background: Benign  prostatic hyperplasia (BPH)  is a noncancerous increase of  the size of the prostate gland. The two main medication classes for BPH management are alpha blockers  and 5α -reductase inhibitors .Urinary bladder stones account for 5% of ...
Abraheem Ali, Mohammed Seleem, Ahmed Ali, Mohammed Mohammed   +3 more
doaj   +1 more source